Jacob Chacko is CEO & President at Oric Pharmaceuticals, Inc. (ORIC). They have made 21 open-market trades across 2 companies since 2014, most recently 2025-12-16.
CIK 0001608936
7 open-market purchases totalling $5.9M since 2014, against 14 sales. Across 7 scored buys the stock is down 7.9% at ninety days, and 6.9 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| RXDX | 70,572 | $14.1M |
| ORIC | 615,085 | $7.6M |
| FDMT | 5,000 | $61K |
| Total | $21.8M |
Shares reported on the most recent Form 4, priced at the 2025-12-17 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 43% | 29% | 14% |
| Avg Move | -7.5% | -1.3% | -7.9% |
| Alpha | -4.2% | +0.7% | -6.9% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ORIC | SELL | 2025-12-16 | 2025-12-17 | $9.06 | $605K | -2.1% | +46.9% | +46.5% |
| ORIC | SELL · 10b5-1 | 2025-10-06 | 2025-10-08 | $12.32 | $923K | -12.6% | -12.8% | -42.6% |
| ORIC | SELL · 10b5-1 | 2025-09-30 | 2025-10-02 | $12.03 | $2.1M | +16.0% | +11.9% | -27.9% |
| ORIC | SELL · 10b5-1 | 2025-09-22 | 2025-09-24 | $10.80 | $1.4M | +39.9% | +27.2% | -19.7% |
| ORIC | SELL | 2024-12-16 | 2024-12-17 | $8.28 | $408K | -0.7% | +22.0% | -3.9% |
| ORIC | SELL | 2024-03-06 | 2024-03-08 | $16.21 | $648K | -3.9% | -28.1% | -40.3% |
| ORIC | SELL | 2024-02-06 | 2024-02-08 | $12.24 | $979K | -15.7% | +22.5% | -21.6% |
| ORIC | SELL | 2023-12-15 | 2023-12-19 | $8.58 | $249K | +5.1% | +5.9% | +68.7% |
| ORIC | SELL | 2023-07-10 | 2023-07-11 | $8.01 | $210K | +2.1% | -5.6% | -26.5% |
| ORIC | SELL · 10b5-1 | 2023-07-05 | 2023-07-07 | $8.01 | $35K | -1.7% | -2.8% | -18.6% |
| ORIC | SELL | 2023-06-26 | 2023-06-28 | $8.03 | $161K | +0.5% | +4.6% | -10.8% |
| FDMT | SELL · 10b5-1 | 2023-04-21 | 2023-04-25 | $20.05 | $100K | -18.2% | -15.8% | -11.7% |
| ORIC | SELL | 2022-12-15 | 2022-12-16 | $3.25 | $19K | +62.5% | +80.3% | +53.5% |
| ORIC | SELL | 2022-12-15 | 2023-02-17 | $3.07 | $19K | -2.8% | -2.4% | +7.8% |
| ORIC | BUY | 2022-05-11 | 2022-05-13 | $2.86 | $2.6M | +6.6% | +33.9% | +52.3% |
| ORIC | BUY | 2022-03-23 | 2022-03-25 | $4.95 | $3.2M | +14.5% | -25.5% | -15.6% |
| ORIC | SELL | 2021-09-14 | 2021-09-16 | $25.06 | $298K | -12.8% | -41.3% | -50.4% |
| ORIC | SELL | 2021-09-10 | 2021-09-14 | $25.05 | $288K | -5.0% | -34.4% | -48.9% |
| ORIC | SELL | 2021-09-07 | 2021-09-09 | $25.11 | $305K | +0.8% | -35.8% | -36.5% |
| ORIC | SELL · 10b5-1 | 2021-05-27 | 2021-05-28 | $25.07 | $10K | -12.7% | -21.1% | -9.2% |
| ORIC | SELL | 2021-05-20 | 2021-05-24 | $25.13 | $245K | -15.6% | -22.1% | -11.2% |
| ORIC | SELL | 2021-05-14 | 2021-05-18 | $25.34 | $1.4M | -6.2% | -20.0% | -22.5% |
| ORIC | SELL · 10b5-1 | 2021-05-11 | 2021-05-13 | $25.12 | $56K | -7.4% | -18.9% | -26.2% |
| ORIC | SELL · 10b5-1 | 2021-04-28 | 2021-04-30 | $25.14 | $33K | -0.0% | -4.7% | -28.8% |
| ORIC | SELL · 10b5-1 | 2021-04-01 | 2021-04-05 | $25.09 | $20K | -9.9% | -3.8% | -25.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.